Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
Authors:
Open Access
- 28 December 2015
- journal article
- retracted article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 13 (2) , 1558-1562
Abstract
The poor prognosis of gliomas is to a large extent attributed to the markedly proliferative and invasive nature of the disease. Endocannabinoids have emerged as novel potential anti‑tumor agents. The present study aimed to investigate the anti‑carcinogenic activity of anandamide (AEA), an endocannabinoid, on glioma cells. To assess the functional role of AEA in glioma, the effects of AEA on cell proliferation, migration, invasion, apoptosis and the cell cycle in vitro, and tumor growth in vivo, were investigated. AEA markedly inhibited the proliferation of U251 cells in a dose‑ and time‑dependent manner. Flow cytometric assays revealed that the apoptosis rate of U251 cells upon treatment with AEA was increased. AEA also suppressed the adhesion, migration and invasion capabilities of the U251 cells. Furthermore, AEA inhibited tumor growth in vivo. These results highlighted the potential role of AEA in the tumorigenesis and progression of glioma, and suggested that AEA exhibits therapeutic potential in the management of human glioma.Keywords
This publication has 26 references indexed in Scilit:
- Focal adhesion kinase and its signaling pathways in cell migration and angiogenesisAdvanced Drug Delivery Reviews, 2011
- Pharmacological Synergism Between Cannabinoids and Paclitaxel in Gastric Cancer Cell LinesJournal of Surgical Research, 2009
- Chromosome arm 1q gain associated with good response to chemotherapy in a malignant gliomaJournal of Neurosurgery, 2007
- Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor‐suppressor efficacyJournal of Cellular Physiology, 2006
- Anandamide inhibits adhesion and migration of breast cancer cellsExperimental Cell Research, 2006
- Cannabinoids and cancer: potential for colorectal cancer therapyBiochemical Society Transactions, 2005
- The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosisCell Death & Differentiation, 2003
- Anandamide Induces Apoptosis in Human Cells via Vanilloid ReceptorsJournal of Biological Chemistry, 2000
- The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 2000
- Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cellsFEBS Letters, 1998